Cita APA (7a ed.)
Diepstraten, J., Janssen, E., Hackeng, C., Dongen, E., Wiezer, R., Ramshorst, B., & Knibbe, C. (2015). Population pharmacodynamic model for low molecular weight heparin nadroparin in morbidly obese and non-obese patients using anti-Xa levels as endpoint. European Journal of Clinical Pharmacology, 71(1), 25-35.
Cita Chicago Style (17a ed.)
Diepstraten, Jeroen, Esther Janssen, Christian Hackeng, Eric Dongen, René Wiezer, Bert Ramshorst, y Catherijne Knibbe. "Population Pharmacodynamic Model for Low Molecular Weight Heparin Nadroparin in Morbidly Obese and Non-obese Patients Using Anti-Xa Levels as Endpoint." European Journal of Clinical Pharmacology 71, no. 1 (2015): 25-35.
Cita MLA (9a ed.)
Diepstraten, Jeroen, et al. "Population Pharmacodynamic Model for Low Molecular Weight Heparin Nadroparin in Morbidly Obese and Non-obese Patients Using Anti-Xa Levels as Endpoint." European Journal of Clinical Pharmacology, vol. 71, no. 1, 2015, pp. 25-35.
Precaución: Estas citas no son 100% exactas.